Meet Two Patients Who Received Freedom from the Hospital with SynCardia's Total Artificial Heart

Patients Describe in Their Own Words Life at Home with the Total Artificial Heart in Italy & U.S. While Waiting for a Matching Donor Heart http://www.syncardia.com

Tucson, (PresseBox) - SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today it has added two new patient stories to its website at: http://www.syncardia.com/patient-stories.html

Meet Giuseppe Nicotera: The World's Longest Supported Total Artificial Heart Patient to be Bridged to Transplant

Giuseppe Nicotera was the first patient to be implanted with SynCardia's Total Artificial Heart at San Camillo Hospital in Rome, Italy. Once stable, he was discharged from the hospital to wait for a matching donor heart at home using the portable driver to power his Total Artificial Heart. Nearly two years later, on Feb. 23, 2011, he received his matching donor heart. At 832 days, he is the longest supported Total Artificial Heart patient in the world to be bridged to transplant. San Camillo Hospital completed certification to implant SynCardia's Total Artificial Heart in only two months, performing its first implant the day after completing Phase II in order to save Mr. Nicotera's life... view Giuseppe Nicotera's patient story.

Meet Troy Golden: The 1st Total Artificial Heart Patient at INTEGRIS Baptist Medical Center

Troy Golden, a registered nurse and pastor, was the first patient to be implanted with SynCardia's Total Artificial Heart at INTEGRIS Baptist Medical Center in Oklahoma City, Oklahoma. INTEGRIS performed its first implant just one month after beginning SynCardia's certification process in order to save Mr. Golden's life.

Mr. Golden was switched to the Freedom® portable driver a month after the implant and discharged from the hospital. Using the Freedom driver, Mr. Golden returned to preaching at his church two months after receiving the Total Artificial Heart. He is participating in the FDA-approved IDE clinical study of the Freedom driver and is currently awaiting a matching donor heart at home... view Troy Golden's patient story.

SynCardia Systems Inc

About The SynCardia Temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Similar to a heart transplant, the SynCardia temporary Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers and does not require expensive anti-rejection medication, which can cause subsequent complications.

Originally used as a permanent replacement heart, SynCardia's Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 900 implants of the Total Artificial Heart, accounting for more than 210 patient years of life. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles.

SynCardia Ranked #20 Among World's 50 Most Innovative Companies

In March 2011, Fast Company magazine ranked SynCardia #20 in its annual list of the world's 50 Most Innovative Companies for "giving mobility to artificial heart recipients." Weighing 13.5 lbs, SynCardia's Freedom® portable driver is the world's first wearable driver for powering the Total Artificial Heart both inside and outside the hospital. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.